Drugs Made In America Acquisition II Corp. (DMIIU) Total Non-Current Liabilities (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Total Non-Current Liabilities of $17.5 million for Q4 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Total Non-Current Liabilities (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Total Non-Current Liabilities for 1 consecutive years, with $17.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $17.5 million; the TTM figure through Dec 2025 stood at $17.5 million (changed N/A YoY), while the FY2025 annual figure was $17.5 million, changed N/A from the prior year.
- Total Non-Current Liabilities held at $17.5 million in Q4 2025 per DMIIU's latest filing.
- Across five years, Total Non-Current Liabilities topped out at $17.5 million in Q4 2025 and bottomed at $17.5 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.50 Mn |